Trials / Unknown
UnknownNCT04108494
A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy
A Single-center, Randomized, Controlled Trial to Evaluate Total Versus Partial Omentectomy for Advanced Gastric Cancer in Radical Gastrectomy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 418 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the impact of omentectomy for advanced gastric cancer on patient survival.
Detailed description
Surgical resection is the mainstay of treatment for gastric cancer. The extent of surgical resection includes total or subtotal gastrectomy, D2 lymphadenectomy, and prophylactic or therapeutic resection of the surrounding organs or tissues (e.g., omentum, peritoneum, etc). However, the oncologic importance of omentectomy during gastrectomy remains unclear. The European guidelines do not give any advice regarding omentectomy, whereas the most recent American guidelines advise to resect both the greater and lesser omentum. Alternatively, the Japanese gastric cancer treatment guidelines recommends preservation of the greater omentum at \>3 cm from the gastroepiploic arcade for patients with T1-T2 tumors and total omentectomy for patients with T3-T4 tumors. In order to evaluate the impact of omentectomy for advanced gastric cancer on patient survival, we designed this trial. Patients who received curative gastrectomy were divided into two groups based on whether they underwent omentectomy. The primary endpoint is the 3-year relapse-free survival rate and the secondary endpoints are 5-year overall survival, and postoperative morbidity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Type of omentectomy | Partial omentectomy with preservation of the greater omentum at \>3 cm from the gastroepiploic arcade.Control group with total omentectomy. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2020-12-31
- Completion
- 2025-12-31
- First posted
- 2019-09-30
- Last updated
- 2019-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04108494. Inclusion in this directory is not an endorsement.